share_log

23% Of This Select Medical Holdings Insider's Holdings Were Sold

23% Of This Select Medical Holdings Insider's Holdings Were Sold

該精選醫療控股公司內幕持股中有 23% 已出售
Simply Wall St ·  2023/12/15 19:21

From what we can see, insiders were net sellers in Select Medical Holdings Corporation's (NYSE:SEM ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it.

據我們所見,在過去的12個月中,內部人士是Select Medical Holdings Corporation(紐約證券交易所代碼:SEM)的淨賣家。也就是說,內部人士出售股票的數量超過了他們購買的數量。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

儘管在長期投資方面,內幕交易並不是最重要的事情,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。

See our latest analysis for Select Medical Holdings

查看我們對精選醫療控股的最新分析

Select Medical Holdings Insider Transactions Over The Last Year

精選去年的醫療控股內幕交易

Over the last year, we can see that the biggest insider sale was by the Senior Vice President of Compliance & Audit, Robert Breighner, for US$296k worth of shares, at about US$29.45 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$24.94. So it may not shed much light on insider confidence at current levels. Robert Breighner was the only individual insider to sell over the last year.

去年,我們可以看到,最大的內幕出售是合規與審計高級副總裁羅伯特·佈雷格納(Robert Breighner),以每股約29.45美元的價格出售了價值29.6萬美元的股票。雖然我們通常不喜歡看到內幕拋售,但更令人擔憂的是銷售是否以較低的價格進行。好消息是,這次大甩賣的價格遠高於目前的24.94美元。因此,在目前的水平上,它可能無法爲內部人士的信心提供太多啓示。羅伯特·佈雷格納是去年唯一一位賣出的個人內部人士。

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

您可以看到下圖所示的去年的內幕交易(公司和個人)。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
NYSE:SEM Insider Trading Volume December 15th 2023
紐約證券交易所:SEM 內幕交易量 2023 年 12 月 15 日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。

Does Select Medical Holdings Boast High Insider Ownership?

Select Medical Holdings是否擁有很高的內幕

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Select Medical Holdings insiders own about US$572m worth of shares (which is 18% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

許多投資者喜歡檢查公司有多少股份由內部人士擁有。我認爲,如果內部人士擁有該公司的大量股份,那將是一個好兆頭。精選醫療控股內部人士擁有價值約5.72億美元的股份(佔該公司的18%)。我喜歡看到這種程度的內部所有權,因爲它增加了管理層考慮股東最大利益的機會。

So What Does This Data Suggest About Select Medical Holdings Insiders?

那麼,這些數據對精選的醫療控股內部人士有什麼啓示呢?

It doesn't really mean much that no insider has traded Select Medical Holdings shares in the last quarter. It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of Select Medical Holdings insider transactions don't fill us with confidence. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To help with this, we've discovered 2 warning signs (1 is a bit concerning!) that you ought to be aware of before buying any shares in Select Medical Holdings.

上個季度沒有內部人士交易過Select Medical Holdings的股票,這並不意味着什麼。令人鼓舞的是,內部人士擁有大量股票,但我們希望看到更多的內幕買盤,因爲去年Select Medical Holdings的內幕交易並沒有使我們充滿信心。因此,儘管了解內部人士在買入或賣出方面的所作所爲很有幫助,但了解特定公司面臨的風險也很有幫助。爲了幫助解決這個問題,我們發現了 2 個警告標誌(1 個有點令人擔憂!)在購買Select Medical Holdings的任何股票之前,你應該意識到這一點。

Of course Select Medical Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Select Medical Holdings可能不是最值得買入的股票。因此,您可能希望看到這些免費的高質量公司集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論